Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

(1) Background: This study aimed to develop a comprehensive understanding of the treatment-related adverse events when using PD-1 or PD-L1 inhibitors in triple-negative breast cancer (TNBC). (2) Methods: We conducted a meta-analysis of Phase II/III randomized clinical trials. Studies were searched f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yixi, Wang, Jingyuan, Hu, Taobo, Wang, Huina, Long, Mengping, Liang, Baosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787874/
https://www.ncbi.nlm.nih.gov/pubmed/36556355
http://dx.doi.org/10.3390/life12121990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787874/
https://www.ncbi.nlm.nih.gov/pubmed/36556355
http://dx.doi.org/10.3390/life12121990

Ejemplares similares